HomeCOVID-19 treatment studies for Vitamin D COVID-19 treatment studies for Vitamin D C19 studies: Vitamin D Vitamin D Select treatmentSelect treatmentTreatmentsTreatments
Assiri et al., COVID-19 related treatment and outcomes among COVID-19 ICU patients: A retrospective cohort study, Journal of Infection and Public Health, doi:10.1016/j.jiph.2021.08.030
Retrospective 118 ICU patients in Saudi Arabia showing no significant differences in unadjusted results with zinc, vitamin D, and favipiravir treatment.
This study is excluded in the after exclusion results of meta
analysis:
unadjusted results with no group details.
risk of death, 66.5% higher, RR 1.66, p = 0.60, treatment 12 of 90 (13.3%), control 2 of 28 (7.1%), inverted to make RR<1 favor treatment, odds ratio converted to relative risk.
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.